spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare Industry NewsFeed

 HSMN NewsFeed - 9 Dec 2020
Sirtex Medical announces strategic investment in BlackSwan Vascular, Inc.
Devices Oncology Venture Capital
 HSMN NewsFeed - 9 Dec 2020
Valeo Pharma Announces Health Canada Approval for Redesca(TM) and Redesca Hp(TM)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 9 Dec 2020
Zimmer Biomet and Hospital for Special Surgery (HSS) Partner to Advance Innovation on mymobility(R) with Apple Watch(R) Remote Care Management System
Devices Orthopaedic
 HSMN NewsFeed - 9 Dec 2020
Mesa Biotech Receives 510(k) Clearance and CLIA Waiver for Its Accula(TM) Strep A Molecular Point of Care Test
Diagnostics FDA
 HSMN NewsFeed - 8 Dec 2020
Amgen's Sotorasib Granted Breakthrough Therapy Designation for Advanced or Metastatic Non-Small Cell Lung Cancer Patients with KRAS G12C Mutation
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Dec 2020
Smith & Nephew announces RI.INSIGHTS - a global data analytics platform designed to advance the standard of care for robotics-assisted joint replacement procedures
Devices Orthopaedic
 HSMN NewsFeed - 8 Dec 2020
Remix Therapeutics Launches with $81 Million Financing to Develop Small Molecule Therapies Designed to Reprogram RNA Processing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Dec 2020
Vertos Medical Announces ASC Reimbursement Increase for the mild(R) Procedure
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 8 Dec 2020
Elekta reports major milestones achieved in MR-guided radiotherapy
Devices Oncology
 HSMN NewsFeed - 7 Dec 2020
KaliVir Immunotherapeutics and Astellas Enter Worldwide Exclusive Licensing Agreement for Development and Commercialization of VET2-L2 Novel Oncolytic Virus
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 4 Dec 2020
CMS grants transitional pass-through (TPT) payment for Stryker's SpineJack(R) System
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 4 Dec 2020
PTC Announces Translarna(TM) Approval in Russia for the Treatment of Duchenne Muscular Dystrophy
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 4 Dec 2020
Marizyme, Inc. Expands Executive Team, Board of Directors
Devices Surgery Cardiology Personnel
 HSMN NewsFeed - 3 Dec 2020
NeuroOne(R) Medical Technologies Corporation Announces First Human Commercial Use of its Evo(TM) Cortical Electrode at Mayo Clinic
Devices Neurosurgery
 HSMN NewsFeed - 3 Dec 2020
Neuroglee Therapeutics to Attack Alzheimer's Disease Through Personalized AI-Powered Digital Therapeutics
Devices Neurology Venture Capital
 HSMN NewsFeed - 3 Dec 2020
Merck KGaA, Darmstadt, Germany and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Dec 2020
V-Wave Announces Appointment of Bill Hughes as Chief Financial Officer
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 2 Dec 2020
HiberCell Bolsters Leadership Team with Appointment of Joseph Talamo as Chief Financial Officer and Promotion of Ari Nowacek, M.D., Ph.D., to Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Dec 2020
Obiltoxaximab Receives Marketing Authorization From European Commission For The Treatment Of Inhalation Anthrax
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 2 Dec 2020
Abbott's FreeStyle Libre 2 Now Approved for Adults and Children with Diabetes in Canada, Featuring Unsurpassed 14-Day Accuracy and Optional Alarms
Devices Monitoring Endocrinology Regulatory
 HSMN NewsFeed - 2 Dec 2020
AbbVie and Frontier Medicines Establish Global Partnership to Discover and Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets
Biopharmaceuticals
 HSMN NewsFeed - 1 Dec 2020
Novartis announces FDA approval of Xolair(R) (omalizumab) for adults with nasal polyps
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Dec 2020
Zimmer Biomet Completes Acquisition of A&E Medical Corporation
Devices Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 1 Dec 2020
Actinium Appoints Mary Mei Chen, M.D., Ph.D. as Vice President of Clinical Development
Biopharmaceutical Personnel
 HSMN NewsFeed - 1 Dec 2020
Boston Scientific Signs Definitive Agreement to Divest BTG Specialty Pharmaceuticals Business
Devices Acquisitions
 HSMN NewsFeed - 1 Dec 2020
Study Finds TMVR Procedural Efficiency with use of the VersaCross(R) RF Transseptal Solution
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Nov 2020
PTC Therapeutics Announces Initiation of Global Phase 3 Clinical Trial to Evaluate Vatiquinone in Friedreich Ataxia
Biopharmaceuticals
 HSMN NewsFeed - 30 Nov 2020
Cogent Biosciences Appoints Brad Barnett as Chief Technology Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Nov 2020
Zlatko Rihter assumes position as President and CEO of Mölnlycke
Devices Personnel
 HSMN NewsFeed - 27 Nov 2020
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Extension of PDUFA Date for Pegunigalsidase Alfa for the Proposed Treatment of Fabry Disease
Biopharmaceuticals FDA
More stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!